Capital Research Global Investors 13D and 13G filings for :
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-06-09 12:32 pm Sale | 2023-06-12 | 13G | TEVA PHARMACEUTICAL LTD INDS A TEVA | Capital Research Global Investors | 0 0.000% | -114,793,989 (Position Closed) | Filing |
| 2023-02-13 3:32 pm Sale | 2023-02-14 | 13G | TEVA PHARMACEUTICAL LTD INDS A TEVA | Capital Research Global Investors | 114,793,989 10.300% | -17,556,761 (-13.27%) | Filing |
| 2022-02-11 12:22 pm Purchase | 2022-02-14 | 13G | TEVA PHARMACEUTICAL LTD INDS A TEVA | Capital Research Global Investors | 132,350,750 12.000% | 2,210,503 (+1.70%) | Filing |